Categories AlphaGraphs, Earnings, Health Care
Key highlights from Abbott Laboratories (ABT) Q2 2023 earnings results
Abbott Laboratories (NYSE: ABT) reported second quarter 2023 earnings results today.
Net sales decreased 11.4% year-over-year to $10 billion. Organic sales growth, excluding COVID-19 tests, was 11.5%.
GAAP net income decreased 32% to $1.37 billion, or $0.78 per share, from last year. Adjusted EPS fell 24.5% to $1.08.
For full-year 2023, adjusted EPS is expected to range between $4.30-4.50.
Prior performance
Most Popular
Take-Two Interactive Software (TTWO) Earnings: 4Q24 Key Numbers
Take-Two Interactive Software, Inc. (NASDAQ: TTWO) reported net revenue of $1.40 billion for the fourth quarter of 2024, which was down 3% year-over-year. Net loss was $2.90 billion, or $17.02
Applied Materials (AMAT) Earnings: 2Q24 Key Numbers
Applied Materials, Inc. (NASDAQ: AMAT) reported revenue of $6.65 billion for the second quarter of 2024, which remained flat year-over-year. GAAP net income increased 9% to $1.72 billion and EPS
What to expect when Macy’s (M) reports its Q1 2024 earnings results
Shares of Macy’s, Inc. (NYSE: M) stayed green on Thursday. The stock has gained 23% over the past 12 months. The retailer is scheduled to report its first quarter 2024